Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

LivaNova PLC - Ordinary Shares (NQ:LIVN)

43.98 -0.08 (-0.18%)
Streaming Delayed Price Updated: 1:58 PM EDT, May 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about LivaNova PLC - Ordinary Shares

< Previous 1 2 3 4 5 Next >
Why ForgeRock Shares Are Trading Higher By Over 49%, Here Are 50 Stocks Moving In Tuesday's Mid-Day Session
Gainers FedNat Holding Company (NASDAQ: FNHC) shares jumped 140% to $0.3939. 
Via Benzinga
LivaNova to Announce Third-Quarter 2022 Results
From LivaNova PLC
Via Business Wire
LivaNova's Return on Invested Capital Overview
  
Via Benzinga
Recap: LivaNova Q2 Earnings
  LivaNova (NASDAQ:LIVN) reported its Q2 earnings results on Wednesday, August 3, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Needham Remains Bullish On UK-Based MedTech Stock Citing Upcoming Catalyst
Via Benzinga
Analyst Ratings for LivaNova
Within the last quarter, LivaNova (NASDAQ:LIVN) has observed the following analyst ratings: 
Via Benzinga
LivaNova Board Appoints Brooke Story as a New Director
From LivaNova PLC
Via Business Wire
Why Bed Bath & Beyond Jumped Around 25%; Here Are 68 Biggest Movers From Yesterday
Gainers 
Via Benzinga
LivaNova: Q4 Earnings Insights
LivaNova (NASDAQ:LIVN) reported its Q4 earnings results on Wednesday, February 23, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
Catalent, Tellurian And Other Big Losers From Monday
U.S. stocks closed lower with the Dow Jones dropping around 185 points on Monday. Here is the list of some big stocks moving lower in the previous session. 
Via Benzinga
LivaNova Reports Second-Quarter 2022 Results
From LivaNova PLC
Via Business Wire
LivaNova to Announce Second-Quarter 2022 Results
From LivaNova PLC
Via Business Wire
LivaNova Elects Peter Wilver to Board of Directors
From LivaNova PLC
Via Business Wire
LivaNova to Present at the Goldman Sachs Global Healthcare Conference
From LivaNova PLC
Via Business Wire
Looking Into LivaNova's Return On Capital Employed
Pulled from Benzinga Pro data, LivaNova (NASDAQ:LIVN) posted Q1 earnings of $2.99 million, an increase from Q4 of 134.94%. Sales dropped to $240.20 million, a 11.07% decrease between quarters. 
Via Benzinga
Recap: LivaNova Q1 Earnings
LivaNova (NASDAQ:LIVN) reported its Q1 earnings results on Wednesday, May 4, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings LivaNova reported in-line EPS of $0.48... 
Via Benzinga
LivaNova Reports First-Quarter 2022 Results
From LivaNova PLC
Via Business Wire
LivaNova Initiates Targeted Commercial Launch of the Essenz Patient Monitor for Cardiopulmonary Bypass Procedures
From LivaNova PLC
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022
Upgrades 
Via Benzinga
LivaNova to Announce First-Quarter 2022 Results
From LivaNova PLC
Via Business Wire
LivaNova Announces 250th Unipolar Depression Patient Implanted in RECOVER Clinical Study
From LivaNova PLC
Via Business Wire
7 Top David Einhorn Stock Picks to Add to Your March Buy List
David Einhorn stocks did better than the S&P 500 in Q4 2021, gaining 18.6%, 760 basis points higher. Buy these seven holdings. 
Via InvestorPlace
LivaNova Announces First Patient Implanted in OSPREY Clinical Study for Patients Coping with Obstructive Sleep Apnea
From LivaNova PLC
Via Business Wire
LivaNova Reports Fourth-Quarter and Full-Year 2021 Results
From LivaNova PLC
Via Business Wire
LivaNova to Announce Fourth-Quarter and Full-Year 2021 Results
From LivaNova PLC
Via Business Wire
LivaNova to Present Scientific Data on VNS Therapy for Drug-Resistant Epilepsy at American Epilepsy Society 2021 Annual Meeting
From LivaNova PLC
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For December 3, 2021
Upgrades Cowen & Co. upgraded the previous rating for Marvell Technology Inc (NASDAQ: 
Via Benzinga
LivaNova to Present Scientific Data on VNS Therapy for Difficult-to-Treat Depression at 4th International Brain Stimulation Conference
From LivaNova PLC
Via Business Wire
LivaNova to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
From LivaNova PLC
Via Business Wire
LivaNova Comments on Decision by Court of Appeal of Milan
From LivaNova PLC
Via Business Wire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.